Tag Archives: crizanlizumab

Crizanlizumab; a new, effective drug for sickle cell?

The results of a major, new trial in sickle cell disease (SUSTAIN) have just been published in the New England Journal of Medicine and presented at the American Society of Haematology meeting in San Diego. The trial involved the novel … Continue reading

Posted in drug trials, pain, red cell adhesion, sickle cell disease | Tagged , , , , | Leave a comment